HPSE and breast carcinoma: Brooks & Leathem, [7] conducted a retrospective study spanning 24 years, involving 373 breast cancer patients, of which 293 (79%) had tumours positive for binding of HPA and 80 (21%) had tumours negative for HPA binding.